Trademark: 97107192
Status Date
Thursday, November 9, 2023
Filing Date
Wednesday, November 3, 2021
Published for Opposition
Tuesday, April 19, 2022
5 Pharmaceutical preparations for the prevention and treatment of immune-mediated, autoimmune, inflammatory, respiratory, and rare diseases and disorders; pharmaceutical preparations for preventing and treating diseases and disorders of the skin and blood; pharmaceutical preparations for preventing and treating lesions and tumors
Nov 11, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 9, 2023
Sou Extension 3 Granted
Nov 9, 2023
Sou Extension 3 Filed
Nov 9, 2023
Sou Teas Extension Received
Apr 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 24, 2023
Sou Extension 2 Granted
Apr 24, 2023
Sou Extension 2 Filed
Apr 24, 2023
Sou Teas Extension Received
Oct 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 21, 2022
Sou Extension 1 Granted
Oct 21, 2022
Sou Extension 1 Filed
Oct 21, 2022
Sou Teas Extension Received
Jun 14, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 19, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 19, 2022
Published For Opposition
Apr 12, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 12, 2022
Teas Change Of Correspondence Received
Apr 12, 2022
Teas Change Of Owner Address Received
Mar 30, 2022
Notification Of Notice Of Publication E-Mailed
Mar 11, 2022
Approved For Pub - Principal Register
Mar 11, 2022
Assigned To Examiner
Nov 17, 2021
Preliminary/Voluntary Amendment - Entered
Nov 17, 2021
Assigned To Lie
Nov 9, 2021
Teas Voluntary Amendment Received
Nov 15, 2021
New Application Office Supplied Data Entered
Nov 6, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
